0113-8911-62 : NDC 2026 Code

0113-8911-62 : Guaifenesin, Pseudoephedrine Hydrochloride ( Mucus D )

Additionally :

You can get information about “0113-8911-62” NDC code in 0113-8911-62 in HTML format

HTML | 0113-8911-62 in TXT (Plain Text) format

TXT | 0113-8911-62 in PDF (Portable Document Format)

PDF | 0113-8911-62 in XML format

XML formats.

NDC Code : 0113-8911-62 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "0113-8911-62",
    "PackageDescription": "4 BLISTER PACK in 1 CARTON (0113-8911-62)  / 6 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK",
    "NDC11Code": "00113-8911-62",
    "ProductNDC": "0113-8911",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Mucus D",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Guaifenesin, Pseudoephedrine Hydrochloride",
    "DosageFormName": "TABLET, MULTILAYER, EXTENDED RELEASE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20251003",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA214407",
    "LabelerName": "L. Perrigo Company",
    "SubstanceName": "GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE",
    "StrengthNumber": "1200; 120",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-10-07",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20251003",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}